XML 27 R2.htm IDEA: XBRL DOCUMENT v2.4.0.6
Consolidated Balance Sheets (USD $)
Sep. 30, 2011
Sep. 30, 2010
CURRENT ASSETS    
Cash and cash equivalents $ 7,507,389 $ 6,847,162
Trade receivable, net of allowance for doubtful accounts of $90,789 at September 30, 2010   58,864
Other receivables 1,608,382 871,819
Prepaid expenses and other current assets 110,818 353,930
Marketable securities 634,585  
TOTAL CURRENT ASSETS 9,861,174 8,131,775
PROPERTY AND EQUIPMENT    
Computers, office equipment and furniture 285,266 335,784
Research equipment 3,515 752,850
Software 77,020 150,445
Leasehold improvements   78,594
Property, Plant and Equipment, Gross, Total 365,801 1,317,673
Less: Accumulated depreciation and amortization (340,364) (1,176,404)
PROPERTY AND EQUIPMENT, NET 25,437 141,269
OTHER ASSETS    
Rent deposit   34,735
Patents 1,731,211 2,046,836
Note Receivable, net 2,272,868  
Derivative asset 161,125  
Investment in Nanotope Inc., equity basis 1,649,748 1,812,927
Investment in Leonardo Biosystems Inc., at cost 187,000 187,000
TOTAL OTHER ASSETS 6,001,952 4,081,498
TOTAL ASSETS 15,888,563 12,354,542
CURRENT LIABILITIES    
Accounts payable 576,809 681,563
Accrued expenses 864,511 494,736
Accrued payroll and benefits 195,649 191,425
Derivative liabilities 944,980 2,408,522
Note payable   500,000
TOTAL CURRENT LIABILITIES 2,581,949 4,276,246
LONG-TERM LIABILITIES    
Other non-current liabilities 135,660  
Note payable 606,786  
TOTAL LONG-TERM LIABILITIES 742,446  
Commitments and contingencies      
STOCKHOLDERS' EQUITY    
Preferred stock, $0.001 par value; 5,000,000 shares authorized; no shares issued or outstanding      
Common stock, $0.001 par value; 145,000,000 shares authorized; 8,642,286 and 7,172,014 shares issued and outstanding as of September 30, 2011 and September 30, 2010, respectively 86,423 71,735
Additional paid-in capital 127,476,435 119,716,834
Subscription receivable (900,000)  
Accumulated deficit during the development stage (113,871,752) (110,742,867)
Total Arrowhead Research Corporation stockholders' equity 12,791,106 9,045,702
Noncontrolling interest (226,938) (967,406)
TOTAL STOCKHOLDERS' EQUITY 12,564,168 8,078,296
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 15,888,563 $ 12,354,542